Bibliography
- LOTVALL J: Pharmacological similarities and differences between β2 agonists. Respir. Med. (2001) 95(Suppl. B):S7-S11.
- JOHNSON M: Salmeterol. Med. Res. Rev. (1995) 15:225-257.
- GREEN SA, SPASOFF AP, COLEMAN RA et al.: Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J. Biol. Chem. (1996) 271:24029-24035.
- CURRIE GP: Indacaterol Novartis/SkyePharma. Curr. Opin. Investig. Drugs (2006) 7:457-463.
- KIKKAWA H, ISOGAYA M, NAGAO T, KUROSE H: The role of the seventh transmembrane region in high affinity binding of a β2-selective agonist TA-2005. Mol. Pharmacol. (1998) 53:128-134.
- NORMAN P: Long-acting β2 agonists. Expert Opin. Ther. Patents (2006) 16:99-104.
Patents
- THERAVANCE INC.: WO2004106279 (2004).
- PFIZER LTD: WO2005090287 (2005).
- PFIZER LTD: WO2005090288 (2005).
- PFIZER LTD: WO2005092887 (2005).
- PFIZER LTD: WO2005092860 (2005).
- PFIZER LTD: WO2005092841 (2005).
Websites
- http://clinicaltrials.gov/ct/screen/SimpleSearch Regularly updated information about federally and privately supported clinical research in human volunteers.